 | • レポートコード：MRC2102QY6962 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の過免疫グロブリン市場について種類別（B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他）、用途別（政府機関、民間、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・過免疫グロブリン市場の概要 ・世界の主要地域別過免疫グロブリン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の過免疫グロブリン市場規模2015-2026：種類別（B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他） ・世界の過免疫グロブリン市場規模2015-2026：用途別（政府機関、民間、その他） ・過免疫グロブリンの米国市場規模2015-2020 ・過免疫グロブリンのヨーロッパ市場規模2015-2020 ・過免疫グロブリンの中国市場規模2015-2020 ・過免疫グロブリンの日本市場規模2015-2020 ・過免疫グロブリンの東南アジア市場規模2015-2020 ・過免疫グロブリンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・過免疫グロブリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・過免疫グロブリンの市場動向・機会・課題 ・調査の結論 |
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides “passive” immunity to the patient against an agent. This is in contrast to vaccines that provide “active” immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant “passive” short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides “passive” immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The classification includes the Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Rho(D) Immunoglobulins and others, and the revenue proportion of Rho(D) Immunoglobulins in 2019 is about 33%, with the largest market share.
For Hepatitis B Immunoglobulins Market, Asia & Pacific is the largest market, with more than 90% global market share.
For Rabies Immunoglobulins Market, Asia & Pacific is the largest sales market, with more than 85% global market share.
CSL Behring, Grifols, Biotest are the leaders of the industry, with 60% revenue market share in 2019, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
Market Analysis and Insights: Global Hyperimmune Globulins Market
The global Hyperimmune Globulins market size is projected to reach US$ 2294.7 million by 2026, from US$ 1527.4 million in 2020, at a CAGR of 7.0% during 2021-2026.
Global Hyperimmune Globulins Scope and Market Size
The global Hyperimmune Globulins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hyperimmune Globulins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Hyperimmune Globulins market is segmented into
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Segment by Application, the Hyperimmune Globulins market is segmented into
Government Institutions
Private Sector
Other
The Hyperimmune Globulins market is analysed and market size information is provided by regions (countries). Segment by Application, the Hyperimmune Globulins market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hyperimmune Globulins Market Share Analysis
Hyperimmune Globulins market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hyperimmune Globulins business, the date to enter into the Hyperimmune Globulins market, Hyperimmune Globulins product introduction, recent developments, etc.
The major vendors covered:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
1 Hyperimmune Globulins Market Overview
1.1 Hyperimmune Globulins Product Scope
1.2 Hyperimmune Globulins Segment by Type
1.2.1 Global Hyperimmune Globulins Sales by Type (2020-2026)
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Other
1.3 Hyperimmune Globulins Segment by Application
1.3.1 Global Hyperimmune Globulins Sales Comparison by Application (2020-2026)
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Hyperimmune Globulins Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hyperimmune Globulins Sales Growth Rate (2015-2026)
1.4.2 Global Hyperimmune Globulins Revenue and Growth Rate (2015-2026)
1.4.3 Global Hyperimmune Globulins Price Trends (2015-2026)
2 Hyperimmune Globulins Estimate and Forecast by Region
2.1 Global Hyperimmune Globulins Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hyperimmune Globulins Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hyperimmune Globulins Sales Market Share by Region (2015-2020)
2.2.2 Global Hyperimmune Globulins Revenue Market Share by Region (2015-2020)
2.3 Global Hyperimmune Globulins Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hyperimmune Globulins Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hyperimmune Globulins Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hyperimmune Globulins Estimates and Projections (2015-2026)
2.4.2 Europe Hyperimmune Globulins Estimates and Projections (2015-2026)
2.4.3 China Hyperimmune Globulins Estimates and Projections (2015-2026)
2.4.4 Japan Hyperimmune Globulins Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hyperimmune Globulins Estimates and Projections (2015-2026)
2.4.6 India Hyperimmune Globulins Estimates and Projections (2015-2026)
3 Global Hyperimmune Globulins Competition Landscape by Players
3.1 Global Top Hyperimmune Globulins Players by Sales (2015-2020)
3.2 Global Top Hyperimmune Globulins Players by Revenue (2015-2020)
3.3 Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperimmune Globulins as of 2019)
3.4 Global Hyperimmune Globulins Average Price by Company (2015-2020)
3.5 Manufacturers Hyperimmune Globulins Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hyperimmune Globulins Players (Opinion Leaders)
4 Global Hyperimmune Globulins Market Size by Type
4.1 Global Hyperimmune Globulins Historic Market Review by Type (2015-2020)
4.1.1 Global Hyperimmune Globulins Sales Market Share by Type (2015-2020)
4.1.2 Global Hyperimmune Globulins Revenue Market Share by Type (2015-2020)
4.1.3 Global Hyperimmune Globulins Price by Type (2015-2020)
4.2 Global Hyperimmune Globulins Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hyperimmune Globulins Sales Forecast by Type (2021-2026)
4.2.2 Global Hyperimmune Globulins Revenue Forecast by Type (2021-2026)
4.2.3 Global Hyperimmune Globulins Price Forecast by Type (2021-2026)
5 Global Hyperimmune Globulins Market Size by Application
5.1 Global Hyperimmune Globulins Historic Market Review by Application (2015-2020)
5.1.1 Global Hyperimmune Globulins Sales Market Share by Application (2015-2020)
5.1.2 Global Hyperimmune Globulins Revenue Market Share by Application (2015-2020)
5.1.3 Global Hyperimmune Globulins Price by Application (2015-2020)
5.2 Global Hyperimmune Globulins Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hyperimmune Globulins Sales Forecast by Application (2021-2026)
5.2.2 Global Hyperimmune Globulins Revenue Forecast by Application (2021-2026)
5.2.3 Global Hyperimmune Globulins Price Forecast by Application (2021-2026)
6 United States Hyperimmune Globulins Market Facts & Figures
6.1 United States Hyperimmune Globulins Sales Market Share by Company (2015-2020)
6.2 United States Hyperimmune Globulins Sales Market Share by Type (2015-2020)
6.3 United States Hyperimmune Globulins Sales Market Share by Application (2015-2020)
7 Europe Hyperimmune Globulins Market Facts & Figures
7.1 Europe Hyperimmune Globulins Sales Market Share by Company (2015-2020)
7.2 Europe Hyperimmune Globulins Sales Market Share by Type (2015-2020)
7.3 Europe Hyperimmune Globulins Sales Market Share by Application (2015-2020)
8 China Hyperimmune Globulins Market Facts & Figures
8.1 China Hyperimmune Globulins Sales Market Share by Company (2015-2020)
8.2 China Hyperimmune Globulins Sales Market Share by Type (2015-2020)
8.3 China Hyperimmune Globulins Sales Market Share by Application (2015-2020)
9 Japan Hyperimmune Globulins Market Facts & Figures
9.1 Japan Hyperimmune Globulins Sales Market Share by Company (3015-3030)
9.2 Japan Hyperimmune Globulins Sales Market Share by Type (2015-2020)
9.3 Japan Hyperimmune Globulins Sales Market Share by Application (2015-2020)
10 Southeast Asia Hyperimmune Globulins Market Facts & Figures
10.1 Southeast Asia Hyperimmune Globulins Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Hyperimmune Globulins Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Hyperimmune Globulins Sales Market Share by Application (2015-2020)
11 India Hyperimmune Globulins Market Facts & Figures
11.1 India Hyperimmune Globulins Sales Market Share by Company (2015-2020)
11.2 India Hyperimmune Globulins Sales Market Share by Type (2015-2020)
11.3 India Hyperimmune Globulins Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Hyperimmune Globulins Business
12.1 CSL Behring
12.1.1 CSL Behring Corporation Information
12.1.2 CSL Behring Business Overview
12.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Behring Hyperimmune Globulins Products Offered
12.1.5 CSL Behring Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Grifols Hyperimmune Globulins Products Offered
12.2.5 Grifols Recent Development
12.3 Biotest
12.3.1 Biotest Corporation Information
12.3.2 Biotest Business Overview
12.3.3 Biotest Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Biotest Hyperimmune Globulins Products Offered
12.3.5 Biotest Recent Development
12.4 Kedrion
12.4.1 Kedrion Corporation Information
12.4.2 Kedrion Business Overview
12.4.3 Kedrion Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Kedrion Hyperimmune Globulins Products Offered
12.4.5 Kedrion Recent Development
12.5 CBPO
12.5.1 CBPO Corporation Information
12.5.2 CBPO Business Overview
12.5.3 CBPO Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CBPO Hyperimmune Globulins Products Offered
12.5.5 CBPO Recent Development
12.6 Emergent (Cangene)
12.6.1 Emergent (Cangene) Corporation Information
12.6.2 Emergent (Cangene) Business Overview
12.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Emergent (Cangene) Hyperimmune Globulins Products Offered
12.6.5 Emergent (Cangene) Recent Development
12.7 Kamada
12.7.1 Kamada Corporation Information
12.7.2 Kamada Business Overview
12.7.3 Kamada Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Kamada Hyperimmune Globulins Products Offered
12.7.5 Kamada Recent Development
12.8 CNBG
12.8.1 CNBG Corporation Information
12.8.2 CNBG Business Overview
12.8.3 CNBG Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.8.4 CNBG Hyperimmune Globulins Products Offered
12.8.5 CNBG Recent Development
12.9 Hualan Bio
12.9.1 Hualan Bio Corporation Information
12.9.2 Hualan Bio Business Overview
12.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Hualan Bio Hyperimmune Globulins Products Offered
12.9.5 Hualan Bio Recent Development
12.10 Shanghai RAAS
12.10.1 Shanghai RAAS Corporation Information
12.10.2 Shanghai RAAS Business Overview
12.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Shanghai RAAS Hyperimmune Globulins Products Offered
12.10.5 Shanghai RAAS Recent Development
12.11 Sichuan Yuanda Shuyang
12.11.1 Sichuan Yuanda Shuyang Corporation Information
12.11.2 Sichuan Yuanda Shuyang Business Overview
12.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Products Offered
12.11.5 Sichuan Yuanda Shuyang Recent Development
12.12 ADMA Biologics
12.12.1 ADMA Biologics Corporation Information
12.12.2 ADMA Biologics Business Overview
12.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue and Gross Margin (2015-2020)
12.12.4 ADMA Biologics Hyperimmune Globulins Products Offered
12.12.5 ADMA Biologics Recent Development
13 Hyperimmune Globulins Manufacturing Cost Analysis
13.1 Hyperimmune Globulins Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hyperimmune Globulins
13.4 Hyperimmune Globulins Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hyperimmune Globulins Distributors List
14.3 Hyperimmune Globulins Customers
15 Market Dynamics
15.1 Hyperimmune Globulins Market Trends
15.2 Hyperimmune Globulins Opportunities and Drivers
15.3 Hyperimmune Globulins Market Challenges
15.4 Hyperimmune Globulins Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hyperimmune Globulins Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Hyperimmune Globulins Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Hyperimmune Globulins Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Hyperimmune Globulins Sales (K Units) by Region (2015-2020)
Table 5. Global Hyperimmune Globulins Sales Market Share by Region (2015-2020)
Table 6. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Hyperimmune Globulins Revenue Share by Region (2015-2020)
Table 8. Global Hyperimmune Globulins Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Hyperimmune Globulins Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Hyperimmune Globulins Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Hyperimmune Globulins Revenue Share Forecast by Region (2021-2026)
Table 12. Global Hyperimmune Globulins (K Units) of Key Companies (2015-2020)
Table 13. Global Hyperimmune Globulins Sales Share by Company (2015-2020)
Table 14. Global Hyperimmune Globulins Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Hyperimmune Globulins Revenue Share by Company (2015-2020)
Table 16. Global Hyperimmune Globulins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperimmune Globulins as of 2019)
Table 17. Global Hyperimmune Globulins Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Hyperimmune Globulins Manufacturing Sites and Area Served
Table 19. Manufacturers Hyperimmune Globulins Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Hyperimmune Globulins Players
Table 22. Global Hyperimmune Globulins Sales (K Units) by Type (2015-2020)
Table 23. Global Hyperimmune Globulins Sales Share by Type (2015-2020)
Table 24. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Hyperimmune Globulins Price (K Units) by Type (2015-2020)
Table 26. Global Hyperimmune Globulins Sales Share by Type (2021-2026)
Table 27. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Hyperimmune Globulins Revenue Share by Type (2021-2026)
Table 29. Global Hyperimmune Globulins Price (K Units) by Type (2021-2026)
Table 30. Global Hyperimmune Globulins Sales (K Units) by Application (2015-2020)
Table 31. Global Hyperimmune Globulins Sales Share by Application (2015-2020)
Table 32. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Hyperimmune Globulins Price (K Units) by Application (2015-2020)
Table 34. Global Hyperimmune Globulins Sales (K Units) by Application (2021-2026)
Table 35. Global Hyperimmune Globulins Sales Share by Application (2021-2026)
Table 36. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Hyperimmune Globulins Revenue Share by Application (2021-2026)
Table 38. Global Hyperimmune Globulins Price (K Units) by Application (2021-2026)
Table 39. United States Hyperimmune Globulins Sales (K Units) by Company (2015-2020)
Table 40. United States Hyperimmune Globulins Sales Market Share by Company (2015-2020)
Table 41. United States Hyperimmune Globulins Sales (K Units) by Type (2015-2020)
Table 42. United States Hyperimmune Globulins Sales Market Share by Type (2015-2020)
Table 43. United States Hyperimmune Globulins Sales (K Units) by Application (2015-2020)
Table 44. United States Hyperimmune Globulins Sales Market Share by Application (2015-2020)
Table 45. Europe Hyperimmune Globulins Sales (K Units) by Company (2015-2020)
Table 46. Europe Hyperimmune Globulins Sales Market Share by Company (2015-2020)
Table 47. Europe Hyperimmune Globulins Sales (K Units) by Type (2015-2020)
Table 48. Europe Hyperimmune Globulins Sales Market Share by Type (2015-2020)
Table 49. Europe Hyperimmune Globulins Sales (K Units) by Application (2015-2020)
Table 50. Europe Hyperimmune Globulins Sales Market Share by Type (2015-2020)
Table 51. China Hyperimmune Globulins Sales (K Units) by Company (2015-2020)
Table 52. China Hyperimmune Globulins Sales Market Share by Company (2015-2020)
Table 53. China Hyperimmune Globulins Sales (K Units) by Type (2015-2020)
Table 54. China Hyperimmune Globulins Sales Market Share by Type (2015-2020)
Table 55. China Hyperimmune Globulins Sales (K Units) by Application (2015-2020)
Table 56. China Hyperimmune Globulins Sales Market Share by Application (2015-2020)
Table 57. Japan Hyperimmune Globulins Sales (K Units) by Company (2015-2020)
Table 58. Japan Hyperimmune Globulins Sales Market Share by Company (2015-2020)
Table 59. Japan Hyperimmune Globulins Sales (K Units) by Type (2015-2020)
Table 60. Japan Hyperimmune Globulins Sales Market Share by Type (2015-2020)
Table 61. Japan Hyperimmune Globulins Sales (K Units) by Application (2015-2020)
Table 62. Japan Hyperimmune Globulins Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Hyperimmune Globulins Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Hyperimmune Globulins Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Hyperimmune Globulins Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Hyperimmune Globulins Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Hyperimmune Globulins Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Hyperimmune Globulins Sales Market Share by Application (2015-2020)
Table 69. India Hyperimmune Globulins Sales (K Units) by Company (2015-2020)
Table 70. India Hyperimmune Globulins Sales Market Share by Company (2015-2020)
Table 71. India Hyperimmune Globulins Sales (K Units) by Type (2015-2020)
Table 72. India Hyperimmune Globulins Sales Market Share by Type (2015-2020)
Table 73. India Hyperimmune Globulins Sales (K Units) by Application (2015-2020)
Table 74. India Hyperimmune Globulins Sales Market Share by Application (2015-2020)
Table 75. CSL Behring Corporation Information
Table 76. CSL Behring Description and Business Overview
Table 77. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. CSL Behring Hyperimmune Globulins Product
Table 79. CSL Behring Recent Development
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Grifols Hyperimmune Globulins Product
Table 84. Grifols Recent Development
Table 85. Biotest Corporation Information
Table 86. Biotest Description and Business Overview
Table 87. Biotest Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Biotest Hyperimmune Globulins Product
Table 89. Biotest Recent Development
Table 90. Kedrion Corporation Information
Table 91. Kedrion Description and Business Overview
Table 92. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Kedrion Hyperimmune Globulins Product
Table 94. Kedrion Recent Development
Table 95. CBPO Corporation Information
Table 96. CBPO Description and Business Overview
Table 97. CBPO Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. CBPO Hyperimmune Globulins Product
Table 99. CBPO Recent Development
Table 100. Emergent (Cangene) Corporation Information
Table 101. Emergent (Cangene) Description and Business Overview
Table 102. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Emergent (Cangene) Hyperimmune Globulins Product
Table 104. Emergent (Cangene) Recent Development
Table 105. Kamada Corporation Information
Table 106. Kamada Description and Business Overview
Table 107. Kamada Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Kamada Hyperimmune Globulins Product
Table 109. Kamada Recent Development
Table 110. CNBG Corporation Information
Table 111. CNBG Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. CNBG Description and Business Overview
Table 113. CNBG Hyperimmune Globulins Product
Table 114. CNBG Recent Development
Table 115. Hualan Bio Corporation Information
Table 116. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Hualan Bio Description and Business Overview
Table 118. Hualan Bio Hyperimmune Globulins Product
Table 119. Hualan Bio Recent Development
Table 120. Shanghai RAAS Corporation Information
Table 121. Shanghai RAAS Description and Business Overview
Table 122. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Shanghai RAAS Hyperimmune Globulins Product
Table 124. Shanghai RAAS Recent Development
Table 125. Sichuan Yuanda Shuyang Corporation Information
Table 126. Sichuan Yuanda Shuyang Description and Business Overview
Table 127. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Sichuan Yuanda Shuyang Hyperimmune Globulins Product
Table 129. Sichuan Yuanda Shuyang Recent Development
Table 130. ADMA Biologics Corporation Information
Table 131. ADMA Biologics Description and Business Overview
Table 132. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. ADMA Biologics Hyperimmune Globulins Product
Table 134. ADMA Biologics Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Hyperimmune Globulins Distributors List
Table 138. Hyperimmune Globulins Customers List
Table 139. Hyperimmune Globulins Market Key Trends
Table 140. Hyperimmune Globulins Key Opportunities and Drivers
Table 141. Hyperimmune Globulins Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Hyperimmune Globulins Product Picture
Figure 2. Global Hyperimmune Globulins Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hyperimmune Globulins Market Share by Application in 2020 & 2026
Figure 6. Government Institutions Examples
Figure 7. Private Sector Examples
Figure 8. Other Examples
Figure 9. Global Hyperimmune Globulins Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Hyperimmune Globulins Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Hyperimmune Globulins Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Hyperimmune Globulins Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Hyperimmune Globulins Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Hyperimmune Globulins Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Hyperimmune Globulins Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Hyperimmune Globulins Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Hyperimmune Globulins Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Hyperimmune Globulins Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Hyperimmune Globulins Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Hyperimmune Globulins Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Hyperimmune Globulins Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hyperimmune Globulins Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Hyperimmune Globulins Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Hyperimmune Globulins Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Hyperimmune Globulins Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Hyperimmune Globulins Players Market Share by Revenue in Hyperimmune Globulins 2015 & 2019
Figure 27. Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Hyperimmune Globulins Revenue Share by Type (2015-2020)
Figure 29. Global Hyperimmune Globulins Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Hyperimmune Globulins Revenue Share by Application (2015-2020)
Figure 31. Global Hyperimmune Globulins Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Hyperimmune Globulins Sales Market Share by Type in 2019
Figure 33. United States Hyperimmune Globulins Sales Market Share by Type in 2019
Figure 34. Europe Hyperimmune Globulins Sales Market Share by Company in 2019
Figure 35. Europe Hyperimmune Globulins Sales Market Share by Type in 2019
Figure 36. Europe Hyperimmune Globulins Sales Market Share by Application in 2019
Figure 37. China Hyperimmune Globulins Sales Market Share by Company in 2019
Figure 38. China Hyperimmune Globulins Sales Market Share by Type in 2019
Figure 39. China Hyperimmune Globulins Sales Market Share by Application in 2019
Figure 40. Japan Hyperimmune Globulins Sales Market Share by Company in 2019
Figure 41. Japan Hyperimmune Globulins Sales Market Share by Type in 2019
Figure 42. Japan Hyperimmune Globulins Sales Market Share by Application in 2019
Figure 43. Southeast Asia Hyperimmune Globulins Sales Market Share by Company in 2019
Figure 44. Southeast Asia Hyperimmune Globulins Sales Market Share by Type in 2019
Figure 45. Southeast Asia Hyperimmune Globulins Sales Market Share by Application in 2019
Figure 46. India Hyperimmune Globulins Sales Market Share by Company in 2019
Figure 47. India Hyperimmune Globulins Sales Market Share by Type in 2019
Figure 48. India Hyperimmune Globulins Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Hyperimmune Globulins
Figure 51. Manufacturing Process Analysis of Hyperimmune Globulins
Figure 52. Hyperimmune Globulins Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
皮下免疫グロブリンの世界市場レポート2020 Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that do…- 重症筋無力症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Myasthenia Gravis Drugs Market The global Myasthenia Gravis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Myasthenia Gravis Drugs Scope and Market Size The global Myasthenia …
- 狂犬病ワクチンの世界市場レポート2020 Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus. Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With…
- ヒトB型肝炎免疫グロブリン（IM）の世界市場レポート2020 Market Analysis and Insights: Global Human Hepatitis B Immunoglobulin (IM) Market The global Human Hepatitis B Immunoglobulin (IM) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Human Hepatitis B Immunoglobulin (IM) Sc…
- ヒトB型肝炎免疫グロブリン（HBIG）の世界市場レポート2020 Market Analysis and Insights: Global Human Hepatitis B Immunoglobulin (HBIG) Market The global Human Hepatitis B Immunoglobulin (HBIG) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Human Hepatitis B Immunoglobulin (HB…